V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280005880 | 280003672 | 1.75 | 93.2 | Palliative (P) | 2015-11-24 | 2015-12-21 | ECarboX | N | N | 280029867 | TRABECTEDIN |
| 280005881 | 280007976 | null | 102.35 | null | 2014-05-17 | 2014-06-06 | CETUXIMAB + CISPLATIN + FU | N | N | 280029869 | CAPECITABINE + OXALIPLATIN |
| 280005882 | 280003673 | 1.89 | 93.1 | Curative (C) | 2015-11-30 | 2015-12-01 | Gemcitabine weekly | N | N | 280029870 | DA |
| 280005883 | 280003673 | 1.6 | 89 | Palliative (P) | 2017-11-15 | 2017-12-06 | Bortezomib + CYCLOPHOSPHAMIDE | 02 | N | 280029870 | DOCETAXEL |
| 280005884 | 280003674 | 1.76 | 83.8 | Palliative (P) | 2016-08-21 | 2016-08-21 | Gemcitabine weekly | N | N | 280029872 | GEMCITABINE |
| 280005885 | 280003675 | 1.59 | 62.4 | Curative (C) | 2015-04-16 | 2015-05-12 | IVADo | N | Y | 280029873 | DE-ESCALATE TRIAL |
| 280005886 | 280003675 | 1.83 | 84 | Palliative (P) | 2017-08-09 | 2017-11-28 | CARBOPLATIN + GEMCITABINE | N | N | 280029873 | DOCETAXEL + GEMCITABINE |
| 280005887 | 280003676 | null | 90.1 | Palliative (P) | 2014-07-08 | 2014-07-14 | GEMCITABINE + NAB PACLITAXEL | N | N | 280029883 | DOCETAXEL |
| 280005888 | 280003676 | 1.62 | 43 | Curative (C) | 2019-01-04 | 2019-01-23 | Fluorouricil + Folonic Acid (MdG) | N | N | 280029883 | DE-ESCALATE TRIAL |
| 280005889 | 280003677 | 1.72 | 76.1 | null | 2014-10-18 | 2014-10-20 | Cisplatin + Doxorubicin | N | N | 280029887 | CISPLATIN + FLUOROURACIL + RT |
| 280005890 | 280003678 | 1.64 | 70.8 | Curative (C) | null | 2016-09-08 | Doxorubicin + Olaratumab | N | N | 280029890 | EURO-EWING |
| 280005891 | 280003678 | 1.66 | 56 | Palliative (P) | null | 2016-09-11 | Cisplatin + Etoposide (3 day) | null | null | 280029890 | PAZOPANIB |
| 280005892 | 280003678 | null | 93.2 | null | 2014-06-26 | 2014-07-08 | STS Rhabdomyosarcoma RMS 2005 IVADo | 2 | N | 280029890 | CARBOPLATIN + PACLITAXEL + RT |
| 280005893 | 280003679 | null | null | Palliative (P) | 2015-05-03 | 2015-05-22 | Capecitabine + Cisplatin + RT | 02 | N | 280029893 | CETUXIMAB + CISPLATIN + FU |
| 280005894 | 280003680 | 1.73 | 65.5 | null | 2015-10-27 | 2015-11-10 | GemCarbo Days 1+8 | N | N | 280029894 | IVADO |
| 280005895 | 280003680 | 1.63 | 59.4 | null | 2014-02-08 | 2014-02-13 | Cisplatin + Fluorouracil + RT 5day | N | N | 280029894 | ETOPOSIDE |
| 280005896 | 280003681 | 0 | 90.8 | Palliative (P) | 2014-04-04 | 2014-04-24 | Capecitabine + Cisplatin | 2 | N | 280029896 | CARBO + FLUOROURACIL |
| 280005897 | 280003681 | 0.84 | null | Curative (C) | 2017-04-06 | 2017-04-13 | Irinotecan + De Gramont | N | N | 280029896 | EURO-EWING |
| 280005898 | 280003681 | 1.71 | 74.6 | Palliative (P) | 2013-02-10 | 2013-02-10 | Cisplatin + Etoposide (5 day) | 02 | N | 280029896 | DOXORUBICIN + OLARATUMAB |
| 280005899 | 280003682 | 1.66 | null | Palliative (P) | null | 2014-06-08 | GemCarbo Days 1+8 | null | null | 280029912 | DOXORUBICIN + OLARATUMAB |
| 280005900 | 280003682 | null | 131.8 | Adjuvant (A) | null | 2015-02-27 | Gemcitabine weekly | N | N | 280029912 | VIDE |
| 280005901 | 280003683 | null | 58.3 | Neo-adjuvant (N) | 2013-03-27 | 2013-04-22 | Gemcitabine weekly | N | N | 280029915 | CARBO + FLUOROURACIL |
| 280005902 | 280003684 | 0.76 | null | Adjuvant (A) | 2014-05-18 | 2014-05-29 | Mitomycin Intravesical | 02 | N | 280029917 | FEC |
| 280005903 | 280007984 | 0 | 57 | Palliative (P) | 2015-08-08 | 2015-08-26 | ECX | N | N | 280029919 | CYCLOPHOSPHAMIDE |
| 280005904 | 280003685 | 1.59 | 73.2 | Curative (C) | 2017-06-11 | 2017-06-23 | EW EuroEwing 99 : VIDE | N | N | 280029922 | IVA |
| 280005905 | 280007985 | 1.8 | 60 | Palliative (P) | 2014-01-02 | 2014-01-14 | CARBOPLATIN + CETUXIMAB + FU | N | N | 280029923 | IFOSFAMIDE |
| 280005906 | 280007985 | 0 | 83 | Neo-adjuvant (N) | 2013-04-02 | 2013-04-02 | Carboplatin+Fluorouracil 4 or 5 day | Y | N | 280029923 | PACLITAXEL |
| 280005907 | 280003686 | 1.7 | 60 | Palliative (P) | 2014-08-14 | 2014-08-14 | DARS Trial | 2 | N | 280029929 | AC |
| 280005908 | 280003686 | 1.63 | null | Neo-adjuvant (N) | 2014-06-07 | 2014-06-20 | Capecitabine | null | null | 280029929 | IMATINIB |
| 280005909 | 280003687 | 1.67 | 54 | Curative (C) | 2015-06-17 | 2015-06-28 | Oxaliplatin + Modified de Gramont | N | N | 280029931 | IVA |
| 280005910 | 280003687 | null | 82 | Palliative (P) | 2016-03-19 | 2016-03-23 | Gemcitabine 1000mg/m2 D1 8 15 | 2 | N | 280029931 | CAV |
| 280005911 | 280003687 | 1.61 | 59.6 | null | 2015-08-31 | 2015-08-31 | Oxaliplatin + Modified de Gramont | N | N | 280029931 | IVADO |
| 280005912 | 280011100 | 1.73 | 109.9 | Palliative (P) | 2017-09-29 | 2017-10-06 | Paclitaxel 7 day | 2 | N | 280029935 | DOCETAXEL + GEMCITABINE |
| 280005913 | 280003688 | 1.69 | 75.8 | Curative (C) | 2015-08-23 | 2015-09-03 | Capecitabine | 02 | N | 280029938 | DE-ESCALATE TRIAL |
| 280005914 | 280003689 | 1.63 | 61.8 | Adjuvant (A) | 2016-07-05 | 2016-07-13 | CISPLATIN + ETOPOSIDE | 2 | N | 280029939 | CAPECITABINE + OXALIPLATIN |
| 280005915 | 280007988 | 1.68 | 57.4 | Palliative (P) | 2017-06-18 | 2017-06-27 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 2 | N | 280029950 | CETUXIMAB + CISPLATIN + FU |
| 280005916 | 280003690 | 1.59 | null | Palliative (P) | 2014-10-09 | 2014-10-24 | STS Rhabdomyosarcoma RMS 2005 IVA | 02 | N | 280029951 | CAPECITABINE + CARBOPLATIN + EPIRUBICIN |
| 280005917 | 280003690 | null | null | null | 2015-11-04 | 2015-11-18 | ECX | null | null | 280029951 | CISPLATIN + FLUOROURACIL + RT |
| 280005918 | 280003691 | null | null | Curative (C) | null | 2014-10-30 | BENDAMUSTINE + RITUXIMAB | null | null | 280029953 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 280005919 | 280003692 | 1.94 | 103.7 | Neo-adjuvant (N) | 2013-04-02 | 2013-04-02 | DOCETAXEL + GEMCITABINE | 2 | N | 280029957 | VIDE |
| 280005920 | 280003693 | 1.68 | 72.8 | Palliative (P) | 2018-05-22 | 2018-05-30 | Oxaliplatin + Modified de Gramont | N | N | 280029958 | CISPLATIN + PEMETREXED |
| 280005921 | 280003693 | 1.73 | 85.7 | Palliative (P) | 2017-04-13 | 2017-04-16 | CARBOPLATIN + CETUXIMAB | N | null | 280029958 | DOXORUBICIN + OLARATUMAB |
| 280005922 | 280003694 | 1.71 | 62.5 | Curative (C) | null | 2016-02-27 | Paclitaxel 7 day | null | null | 280029966 | DE-ESCALATE TRIAL |
| 280005923 | 280003695 | 1.69 | 78.8 | Palliative (P) | 2016-11-30 | 2016-12-07 | Capecitabine (14 days)+Carboplatin | N | N | 280029967 | LIPOSOMAL DOXORUBICIN |
| 280005924 | 280003696 | 1.86 | 8.9 | Adjuvant (A) | 2015-06-05 | 2015-06-09 | Carboplatin + Pemetrexed | 02 | null | 280029968 | EURO-EWING |
| 280005925 | 280003696 | 1.75 | 67.6 | null | 2013-12-01 | 2013-12-01 | Cetuximab +Cisplatin + FU (Cycle 1) | N | N | 280029968 | IVADO |
| 280005926 | 280003697 | 1.98 | 64 | Palliative (P) | 2017-01-09 | 2017-01-09 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | N | null | 280029973 | DOXORUBICIN + OLARATUMAB |
| 280005927 | 280003697 | null | null | Curative (C) | 2015-11-09 | 2015-11-19 | Carboplatin + Pemetrexed | null | N | 280029973 | CISPLATIN + FLUOROURACIL + RT |
| 280005928 | 280003697 | 1.78 | null | null | 2016-10-17 | 2016-11-13 | FLUOROURACIL + MITOMYCIN + RT | N | Y | 280029973 | EC |
| 280005929 | 280003698 | 1.63 | 55 | Palliative (P) | 2018-07-03 | 2018-07-09 | Abiraterone | N | N | 280029981 | LIPOSOMAL DOXORUBICIN |